Skip to main content
Clinical Trials/NCT05883774
NCT05883774
Not yet recruiting
Not Applicable

Effects of Repetitive Transcranial Magnetic Stimulation on the Anxiety State of Older Patients With Generalized Anxiety Disorder

Yi Yang1 site in 1 country100 target enrollmentDecember 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Generalized Anxiety Disorder
Sponsor
Yi Yang
Enrollment
100
Locations
1
Primary Endpoint
Differences in HAMA scores after 10 sessions of rTMS/sham-rTMS between two groups.
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to evaluate the effects of low-frequency repetitive transcranial magnetic stimulation on anxiety state in older patients with generalized anxiety disorder.

Detailed Description

Repetitive transcranial magnetic stimulation can alter nerve cell excitability, improve cerebral blood flow and metabolism, and is widely used in neuropsychiatric research. Studies have shown its efficiency and safety in treating anxiety disorders, however the senior patient group has not been adequately validated. The purpose of this study is to evaluate the effects of low-frequency repetitive transcranial magnetic stimulation on anxiety state in older patients with generalized anxiety disorder.

Registry
clinicaltrials.gov
Start Date
December 1, 2024
End Date
December 1, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Yi Yang
Responsible Party
Sponsor Investigator
Principal Investigator

Yi Yang

Vice President of First Hospital of Jilin University

The First Hospital of Jilin University

Eligibility Criteria

Inclusion Criteria

  • 1)Age≥60 years, regardless of gender.
  • 2)Meets the diagnostic criteria for generalized anxiety disorder in the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-V) developed by the American Psychiatric Association.
  • 3)HAMA score≥14 and HAMD-17 items score \<
  • 4)No adjustment in the type and dose of anti-anxiety medication in the 3 months prior to randomization.
  • 5)Willing to participate and sign the informed consent.

Exclusion Criteria

  • 1)Traumatic brain injury or other conditions affecting the brain, such encephalitis, brain tumors, or intracranial hypertension.
  • 2)Previous history of epilepsy, family history of epilepsy or presence of seizure provoking factors or alcohol abuse.
  • 3)History of other psychiatric disorders such as current post-traumatic stress disorder, substance use disorder (within 6 months), bipolar disorder and obsessive-compulsive disorder.
  • 4)Unstable mental state with impulses toward self-harm or suicide.
  • 5)Presence of intracranial metal implant, cochlear implant, built-in pulse generator (such as cardiac pacemaker), etc.
  • 6)Medical or surgical disorders that are severe or unstable.
  • 7)Pregnancy or breastfeeding.
  • Those who are participating in other clinical research or has participated in other clinical research or has participated in this study within 3 months prior to enrollment.
  • Other conditions that the researchers think are not suitable for the project.

Outcomes

Primary Outcomes

Differences in HAMA scores after 10 sessions of rTMS/sham-rTMS between two groups.

Time Frame: baseline; 10 days

The HAMA scale consists of 14 items, each with a score ranging from 1 to 4, for a total score ranging from 14 to 56, and the degree of anxiety correlates positively with the score.

Study Sites (1)

Loading locations...

Similar Trials